Arlo Technologies, Inc.

ARLO

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 1,951,869Value: $27.3M

**Signal Note: Driehaus New Position in ARLO** Driehaus Capital's $27.3M entry into Arlo Technologies appears misaligned with typical biotech thesis—ARLO is a consumer pet tech company (cloud-connected pet cameras), not a pharmaceutical or therapeutic developer. This position likely reflects either a data error in the filing or a non-core venture/growth equity allocation rather than a core biotech bet. Recommend clarifying position rationale and confirming filing accuracy before assigning analytical weight.

More ARLO Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: